title: Reduced response to an estrous induction program in postpartum beef cows treated with zilpaterol and gaining body weight.
abstract: In beef cows, reduced energy intake delays first ovulation postpartum and is associated with lesser insulin, IGF-I and leptin concentrations. However, the close relationship among these hormones mask their individual roles in the reinitiation of ovarian activity. A β-adrenergic receptor agonist (βAR) was used to increase body condition score (BCS) and yet reduce body fat and leptin serum concentration to determine the specific role of leptin in the postpartum ovarian activity. Beef cows (n=77) with BCS 3.1 ± 1.4 received 2 kg/day of feed containing 0 or 0.15 mg/kg of zilpaterol (a synthethic βAR), for 33 days. Estrus was induced with a progestin implant applied for 9 d and cows in estrus were bred by artificial insemination (AI). Zilpaterol administration increased (P<0.05) daily weight gain, muscle depth and BCS, with no changes in back fat depth, reducing fat to muscle ratio (P<0.05). At the time of AI, insulin (38%) and IGF-I (26%) concentrations were less in zilpaterol-treated cows (P<0.05), but leptin concentration was unaffected. Ovulation rate and animal with luteal activity after estrus induction were also reduced by 35% (P=0.05) and 56.5% (P=0.007), respectively, in zilpaterol-treated cows. Logistic regression estimates for BCS (P=0.016) and IGF-I concentration (P=0.03) were positively related with the occurrence of luteal activity. In addition, whilst back fat (P=0.009) had a positive effect on luteal activity, leptin concentration did not show a significant relationship. In conclusion, despite an increase in body weight and a positive change in BCS, the reduction in insulin and IGF-I concentrations, associated with βAR treatment, reduced the response to induction of estrus. However only IGF-I, but not leptin or insulin, significantly influenced the odds for the occurrence of luteal activity after estrous induction in cattle with poor BCS.
authors.affiliation: Universidad Nacional Autónoma de México, Facultad de Medicina Veterinaria, Mexico, DF, Mexico.
authors.forename: A
authors.initials: A
authors.lastname: Guzmán
authors.forename: E
authors.initials: E
authors.lastname: Gonzalez-Padilla
authors.forename: P
authors.initials: P
authors.lastname: Garcés-Yépez
authors.forename: J V
authors.initials: JV
authors.lastname: Rosete-Fernandez
authors.forename: R C
authors.initials: RC
authors.lastname: Calderón-Robles
authors.forename: C
authors.initials: C
authors.lastname: Murcia
authors.forename: C G
authors.initials: CG
authors.lastname: Gutiérrez
mesh_terms: D000818:Animals; D001823:Body Composition / Q000187:drug effects; D002417:Cattle; D004343:Drug Implants; D030762:Estrous Cycle / Q000187:drug effects*; D004973:Estrus Synchronization / Q000379:methods*; D005260:Female; D049590:Postpartum Period; D011247:Pregnancy; D011372:Progestins / Q000008:administration & dosage / Q000494:pharmacology*; D014297:Trimethylsilyl Compounds / Q000494:pharmacology*; D015430:Weight Gain / Q000187:drug effects*
chemical_list: D004343:Drug Implants; D011372:Progestins; D014297:Trimethylsilyl Compounds; C475840:Zilpaterol